American Oncology Network Stock Price, News & Analysis

Florida Oncology and Hematology, a partner practice of American Oncology Network (AON), has relocated its Health Parkway clinic in Naples to a larger facility at 15455 Collier Blvd., Suite 101 in the Lintree Medical Plaza. The expanded clinic features enhanced services including PET services, an infusion room, additional private exam rooms, in-house lab and pathology services, and an onsite specialty pharmacy for oral oncolytics.

Board-certified medical oncologist Dr. Ferdy Santiago and Board-certified hematologist Dr. Deborah Glick are now seeing patients at the new location. The practice also recently expanded its other Naples-area clinic at Goodlette-Frank Road in June. Florida Oncology and Hematology operates five clinic locations serving patients in Cape Coral, Clearwater, Fort Myers, Naples, and surrounding areas.

Florida Oncology and Hematology, a partner of American Oncology Network (AONC), has relocated its Naples-Goodlette clinic to a larger facility at 708 Goodlette-Frank Road. The expanded location features additional private exam rooms, an infusion room, in-house lab and pathology services, and an onsite specialty pharmacy for oral oncolytics. Board-certified medical oncologists Dr. Zanetta Lamar, Dr. Ferdy Santiago, and hematologist Dr. Deborah Glick are accepting patients at the new location. The practice, which serves patients across Cape Coral, Clearwater, Fort Myers, Naples, and surrounding areas, aims to provide enhanced cancer care through personalized treatment plans in a community-based setting. The relocation enables the practice to expand patient services, add staff for one-on-one care, and maintain their commitment to affordable, high-quality oncology treatment.

American Oncology Network (AONC) showcased multiple research studies at the ASCO 2025 Annual Meeting in Chicago from May 30-June 3. AON physicians and leaders presented research across various oncology fields, including clinical trials, real-world data analysis, and cost-effectiveness studies. Key presentations covered topics such as neuroendocrine neoplasms, breast cancer treatments, racial representation in clinical trials, pharmacovigilance studies, and cost-effective cancer care through biosimilars. Notable research included studies on ABBV-706 for neuroendocrine neoplasms, Bria-IMT trials in metastatic breast cancer, and multiple real-world analyses of cancer treatments. AON currently offers access to over 150 clinical trials through its network of community oncology practices.

American Oncology Network (AONC) announced the expansion of radioligand therapy (RLT) access across its network, with six community oncology practices now offering these advanced cancer treatments. The network has already administered over 300 treatments to nearly 70 patients across five partner practices.

The practices offer three FDA-approved radiopharmaceuticals: Pluvicto™ for metastatic castration-resistant prostate cancer, Lutathera® for gastroenteropancreatic neuroendocrine tumors, and Xofigo® for symptomatic mCRPC with bone metastases. RLT works by delivering targeted radiation directly to cancer cells while minimizing damage to healthy tissue.

American Oncology Network (AONC) has appointed Joe Verschleiser as Chief Growth and Performance Officer. In his new role, Verschleiser will lead growth strategy and performance optimization for AON partner practices, focusing on expansion and new business line opportunities. He brings over a decade of healthcare experience, including executive leadership roles at Unified Women's Healthcare, where he served as president of the West Division overseeing operations for more than 200 physicians. His previous experience includes positions in financial strategy, mergers and acquisitions, and investment banking at firms like Jefferies and Rothschild & Co.

Dr. Sakeer Hussain, a medical oncologist at Heartland Oncology and Hematology, has been named a 2025 Advocacy Champion by the Association for Clinical Oncology (ASCO). The recognition was announced during ASCO's annual Advocacy Summit in Washington, D.C. Dr. Hussain was honored for his significant contributions to cancer policy advancement, including meetings with congressional leaders, testifying before the Iowa House of Representatives, and hosting his local congressman to showcase community oncology care.

His advocacy work has focused on critical issues such as drug shortages, research funding, telehealth access, prior authorization reform, and opposing non-medical switching. Dr. Hussain's efforts align with ASCO's mission to support high-quality, equitable cancer care, regardless of patients' geography, income, or background.

American Oncology Network (AONC) has appointed Terri Casey as its new Chief Human Resources Officer (CHRO). Casey brings over 15 years of experience leading HR teams, with extensive background in executive leadership roles across various physician specialty practices including orthopedics, rehabilitation, aesthetics, and mental health. She also has significant experience in employment law, having worked at a boutique law firm and served as general counsel specializing in healthcare industry matters.

Casey holds a Bachelor and Master of Science from Virginia Commonwealth University and a Juris Doctor from John Marshall Law School. Prior to this permanent appointment, she served as interim CHRO for several healthcare organizations, including AON. In her new role, she will focus on strengthening workplace culture, talent development, and supporting AON's mission to make cancer care affordable and accessible across communities.

American Oncology Network (AON) announced its participation in 14 speaking sessions at the 2025 Community Oncology Alliance (COA) Annual Conference in Orlando, Florida, April 29-30. The conference, themed 'Empower & Advocate: Independent Community Oncology,' will feature AON leaders discussing various aspects of community oncology.

Chief Medical Officer Dr. Stephen Divers and Chief Strategy Officer Alti Rahman will serve as conference co-chairs. Presentations will cover important topics including:

• Payer contracting and value-based care
• Clinical trials infrastructure
• Patient advocacy and mental health programs
• Radiopharmaceutical therapies
• Practice partnerships and innovation

The event demonstrates AON's commitment to supporting local practices through comprehensive services including in-house pharmacy, lab services, and back-office operations, enabling physicians to focus on community-based patient care.

American Oncology Network (AON) has reported significant success in the first performance period of the Centers for Medicare & Medicaid Innovation's (CMMI) Enhancing Oncology Model (EOM). The company achieved nearly $6M in cost savings for CMS while earning a performance-based payment and improving patient outcomes.

Building on their previous success in the Oncology Care Model (OCM), where they saw a 2.6% decrease in expenditures, AON practices now represent approximately 10% of the total EOM population. The success was driven by several key initiatives implemented in partnership with Thyme Care, including:

• Pharmacy interventions focusing on drug waste minimization and therapeutic substitutions
• 24/7 comprehensive care navigation with virtual support
• Real-time performance data analytics
• Virtual palliative care support